Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer.

  • Palma, Francesco
  • Affinito, Alessandra
  • Nuzzo, Silvia
  • Roscigno, Giuseppina
  • Scognamiglio, Iolanda
  • Ingenito, Francesco
  • Martinez Garcia, Maria Dolores
  • Franzese, Monica
  • Zanfardino, Mario
  • Soricelli, Andrea
  • Fiorelli, Alfonso
  • Condorelli, Gerolama
  • Quintavalle, Cristina
Lung cancer is still the leading cause of death by cancer worldwide despite advances both in its detection and therapy. Multiple oncogenic driver alterations have been discovered, opening the prospective for new potential therapeutic targets. Among them, KRAS mutations represent the most frequent oncogene aberrations in non-small cell lung cancer (NSCLC) patients with a negative prognostic impact, but effective therapies targeting KRAS are not well characterized yet. Here, we demonstrate that the microRNA miR-34c-3p is a positive prognostic factor in KRAS-mutated NSCLC patients. Firstly, looking at the TGCA dataset, we found that high miR-34c-3p expression correlated with longer survival of KRAS-mutated NSCLC patients. In vitro assays on immortalized and patient-derived primary NSCLC cells revealed that miR-34c-3p overexpression increased apoptosis and lowered proliferation rate in KRASmut cells. Computational analysis and in vitro assays identified CDK1, one of the most promising lethal targets for KRAS-mutant cancer, as a target of miR-34c-3p. Moreover, the combination of CDK1 inhibition (mediated by RO3306) and miR-34c-3p overexpression resulted in an additive effect on the viability of KRASmut-expressing cells. Altogether, our findings demonstrate that miR-34c-3p is a novel biomarker that may allow tailored treatment for KRAS-mutated NSCLC patients.
UVaDOC. Repositorio Documental de la Universidad de Valladolid
Publicación Artículo científico (JournalArticle)

The Incorporation of etanercept into a porous tri-layer scaffold for restoring and repairing cartilage tissue

  • Campos, Yaima
  • Fuentes, Gastón
  • Almirall, Amisel
  • Que, Ivo
  • Schomann, Timo
  • Chung, Chih Kit
  • Jorquera Cordero, Carla
  • Quintanilla Sierra, Luis
  • Rodríguez Cabello, José Carlos
  • Chan, Alan
  • Cruz, Luis
Producción Científica, Cartilage diseases currently affect a high percentage of the world’s population. Almost all of these diseases, such as osteoarthritis (OA), cause inflammation of this soft tissue. However, this could be controlled with biomaterials that act as an anti-inflammatory delivery system, capable of dosing these drugs over time in a specific area. The objective of this study was to incorporate etanercept (ETA) into porous three-layer scaffolds to decrease the inflammatory process in this soft tissue. ETA is a blocker of pro-inflammatory cytokines, such as tumour necrosis factor alpha (TNF-α) and interleukin 6 (IL-6). For this reason, the scaffold was built based on natural polymers, including chitosan and type I collagen. The scaffold was grafted next to subchondral bone using hydroxyapatite as filler. One of the biomaterials obtained was also crosslinked to compare its mechanical properties with the non-treated one. Both samples’ physicochemical properties were studied with SEM, microCT and photoacoustic imaging, and their rheological properties were also compared. The cell viability and proliferation of the human chondrocyte C28/I2 cell line were studied in vitro. An in vitro and in vivo controlled release study was evaluated in both specimens. The ETA anti-inflammatory effect was also studied by in vitro TNF-α and IL-6 production. The crosslinked and non-treated scaffolds had rheological properties suitable for this application. They were non-cytotoxic and favoured the in vitro growth of chondrocytes. The in vitro and in vivo ETA release showed desirable results for a drug delivery system. The TNF-α and IL-6 production assay showed that this drug was effective as an anti-inflammatory agent. In an in vivo OA mice model, safranin-O and fast green staining was carried out. The OA cartilage tissue improved when the scaffold with ETA was grafted in the damaged area. These results demonstrate that this type of biomaterial has high potential for clinical applications in tissue engineering and as a controlled drug delivery system in OA articular cartilage., European Union through the Erasmus PLUS doctoral fellowship (project 2015-1-NL01-KA 107-008639), VIDI personal grant (project 723.012.110)
UVaDOC. Repositorio Documental de la Universidad de Valladolid
Publicación Artículo científico (JournalArticle)

The Effects of crosslinking on the rheology and cellular behavior of polymer-based 3D-multilayered scaffolds for restoring articular cartilage

  • Campos, Yaima
  • Sola, Francisco J.
  • Fuentes, Gastón
  • Quintanilla Sierra, Luis
  • Almirall, Amisel
  • Cruz, Luis J
  • Rodríguez Cabello, José Carlos
  • Tabata, Yasuhiko
Producción Científica, Polymer-based tri-layered (bone, intermediate and top layers) scaffolds used for the restoration of articular cartilage were prepared and characterized in this study to emulate the concentration gradient of cartilage. The scaffolds were physically or chemically crosslinked. In order to obtain adequate scaffolds for the intended application, the impact of the type of calcium phosphate used in the bone layer, the polymer used in the intermediate layer and the interlayer crosslinking process were analyzed. The correlation among SEM micrographs, physical-chemical characterization, swelling behavior, rheological measurements and cell studies were examined. Storage moduli at 1 Hz were 0.3–1.7 kPa for physically crosslinked scaffolds, and 4–5 kPa (EDC/NHS system) and 15–20 kPa (glutaraldehyde) for chemically crosslinked scaffolds. Intrinsic viscoelasticity and poroelasticity were considered in discussing the physical mechanism dominating in different time/frequency scales. Cell evaluation showed that all samples are available as alternatives to repair and/or substitute cartilage in articular osteoarthritis., The European Union through the Erasmus MUNDUS LINDO post-doctoral fellowship,(project code ML14PD1157) and Erasmus PLUS doctoral fellowship, (project code 2015-1-NL01-KA 107-008639), European Union’s Horizon 2020 research and innovation program. grant agreement - H2020- MSCA-RISE (644373—PRISAR), H2020-MSCA-RISE (777682—CANCER), H2020-WIDESPREAD-05- 2017-Twinning (807281—ACORN), H2020-WIDESPREAD-2018-03 (852985—SIMICA), H2020-SCA RISE-2016 (734684—CHARMED) and MSCA-ITN-2015-ETN (675743—ISPIC), 861190 (PAVE), 857894 (CAST), 859908 (NOVA-MRI); 872860 (PRISAR2), VIDI grant (project number 723.012.110)
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Opportunities of Bacterial Cellulose to Treat Epithelial Tissues

  • Anton-Sales, Irene|||0000-0003-3511-2574
  • Beekmann, Uwe
  • Laromaine, Anna|||0000-0002-4764-0780
  • Roig i Serra, Anna|||0000-0001-6464-7573
  • Kralisch, Dana
In this mini-review, we highlight the potential of the biopolymer bacterial cellulose to treat damaged epithelial tissues. Epithelial tissues are cell sheets that delimitate both the external body surfaces and the internal cavities and organs. Epithelia serve as physical protection to underlying organs, regulate the diffusion of molecules and ions, secrete substances and filtrate body fluids, among other vital functions. Because of their continuous exposure to environmental stressors, damage to epithelial tissues is highly prevalent. Here, we first compare the properties of bacterial cellulose to the current gold standard, collagen, and then we examine the use of bacterial cellulose patches to heal specific epithelial tissues; the outer skin, the ocular surface, the oral mucosa and other epithelial surfaces. Special emphasis is made on the dermis since, to date, this is the most widespread medical use of bacterial cellulose. It is important to note that some epithelial tissues represent only the outermost layer of more complex structures such as the skin or the cornea. In these situations, depending on the penetration of the lesion, bacterial cellulose might also be involved in the regeneration of, for instance, inner connective tissue.